Humanetics Awarded Exclusive Worldwide Licenses from Henry Ford Hospital Health System for Two Post-Exposure Medical Radiation Countermeasures
8/12/2010 10:04:02 AM
More...
|
Patent Issued for Humanetics' BIO 300 Radiation Countermeasure Drug
3/5/2010 8:51:40 AM
More...
|
Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics
7/13/2009 11:36:46 AM
More...
|
Humanetics Completes Phase I Safety and Pharmacokinetic Trial for New Radiation Countermeasure
1/11/2008 10:26:22 AM
More...
|
Humanetics Receives $3.8 Million from U.S. Department of Defense to Continue Development of Medical Radiation Countermeasures
11/16/2007 6:41:28 AM
More...
|
Humanetics Receives Orphan Drug Designation for Its BIO 300 Radiation Countermeasure
7/20/2007 11:08:24 AM
More...
|